The Spanish startup based in Barcelona that researches regenerative medicine
Rimbarlat has raised €600k across 1 funding round from 1 investor, most recently a round in Oct 2022. Based in Barcelona, Spain; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-03 | Other | €600k |
| Capital Cell |
| View deal → |
